Shares of pharmaceutical major Cipla dropped over 4 per cent on Wednesday at ₹1,417 per share after analysts highlighted near-term challenges following a muted performance in the second quarter results for the current financial year (Q2FY25).
In Q2FY25, Cipla's domestic business underperformed due to seasonal weakness in the anti-infective and trade generics business. However, this was offset by strong growth in Africa, emerging markets, and European business, said analysts. Growth for Cipla was lower in the US and India than analyst estimates.
"The narrative for Cipla has worsened in the recent past, driven by US prospects and a slowdown in India. Supply constraints in Acromegaly drug Lanreotide, potential competition for the drug in due course, a delay in clearance of the Goa site resulting in Cipla failing to have the first-mover advantage (a competitor has gained approval) present potential risks to earnings," analysts at Nomura said in a report.
Esta historia es de la edición October 31, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición October 31, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
How AI is Disrupting the Literary World
This summer, Ayad Akhtar was struggling with the final scene of McNeal, his knotty and disorienting play about a Nobel Prize-winning author who uses artificial intelligence to write a novel.
Dark store surge set to spur realty demand
Quick commerce (qcom) firms are poised to impact India's real estate landscape as they expand their dark store networks to meet the growing demand.
The Bibek I knew
It was the early 2000s when I was setting up an economics research practice.
Saudi revives India investment plans amid shrinking mkt share
Move aimed at ensuring a major captive market for its crude oil, even as Indian refiners mull reducing the share of expensive Saudi grades sourced under term contracts
Tech, threats, territories - navigating industry growth in the new world order
As I step into my role as president of Nasscom, I view the next five years as a critical period, shaped by the intersection of three forces: Technology, threats, and territories.
STARS AND STYLE
The two biggest ever stars of Indian movies have followed contrasting styles as brands
Overhaul of HVLDE norms on cards
Market regulator Sebi has proposed an overhaul to the framework governing high-value listed debt entities (HVLDEs) in a bid to reduce the compliance burden.
Sebi moots changes to ERP framework
Revision to allow ERPs to rate unlisted securities
Testing the Midwestern assumption
Every now and then, a moment comes when the assumptions underlying a nation's politics are completely overturned.
From alienation to acceptance
A third of the way into Matthew Rankin's Universal Language, one stops wanting to know the film's secret and begins swimming in its mystery instead.
